TEVA-PIROXICAM DIN 00695696
Health Canada record
| Active ingredient(s) | PIROXICAM 20 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M01AC01 PIROXICAM |
| Original market date | 31-Dec-1986 |
| Current status date | 15-Jul-2015 |
| Source | Health Canada DPD |
Establishment licence of the holder
Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PIROXICAM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00642886 | APO PIROXICAM CAP 10MG | APOTEX INC | Capsule | PIROXICAM 10 MG | Marketed |
| 00642894 | APO PIROXICAM CAP 20MG | APOTEX INC | Capsule | PIROXICAM 20 MG | Marketed |
| 00695718 | TEVA-PIROXICAM | TEVA CANADA LIMITED | Capsule | PIROXICAM 10 MG | Marketed |
| 02139952 | ALTI-PIROXICAM-CAP 10MG | ALTIMED PHARMA INC. | Capsule | PIROXICAM 10 MG | Cancelled Post Market |
| 02139960 | ALTI-PIROXICAM-CAP 20MG | ALTIMED PHARMA INC. | Capsule | PIROXICAM 20 MG | Cancelled Post Market |
| 02177137 | DOM-PIROXICAM | DOMINION PHARMACAL | Suppository | PIROXICAM 20 MG | Cancelled Post Market |
| 02239536 | DOM-PIROXICAM | DOMINION PHARMACAL | Capsule | PIROXICAM 20 MG | Cancelled Post Market |
| 02239922 | DOM-PIROXICAM | DOMINION PHARMACAL | Capsule | PIROXICAM 10 MG | Cancelled Post Market |
| 02177129 | DOM-PIROXICAM | DOMINION PHARMACAL | Suppository | PIROXICAM 10 MG | Cancelled Post Market |
| 00525596 | FELDENE CAP 10MG | PFIZER CANADA ULC | Capsule | PIROXICAM 10 MG | Cancelled Post Market |
| 00525618 | FELDENE CAP 20MG | PFIZER CANADA ULC | Capsule | PIROXICAM 20 MG | Cancelled Post Market |
| 00632708 | FELDENE SUP 10MG | PFIZER CANADA ULC | Suppository | PIROXICAM 10 MG | Cancelled Post Market |
| 00632716 | FELDENE SUP 20MG | PFIZER CANADA ULC | Suppository | PIROXICAM 20 MG | Cancelled Post Market |
| 02238028 | FEXICAM | TECHNILAB PHARMA INC. | Suppository | PIROXICAM 20 MG | Cancelled Post Market |
| 02171821 | GEN-PIROXICAM - CAP 20MG | GENPHARM ULC | Capsule | PIROXICAM 20 MG | Cancelled Post Market |
| 02171813 | GEN-PIROXICAM-CAP 10MG | GENPHARM ULC | Capsule | PIROXICAM 10 MG | Cancelled Post Market |
| 00865761 | NU-PIROX CAP 10MG | NU-PHARM INC | Capsule | PIROXICAM 10 MG | Cancelled Post Market |
| 00865788 | NU-PIROX CAP 20MG | NU-PHARM INC | Capsule | PIROXICAM 20 MG | Cancelled Post Market |
| 02232550 | PENTA-PIROXICAM CAPSULES | PENTAPHARM LTD. | Capsule | PIROXICAM 20 MG | Cancelled (Unreturned Annual) |
| 02232549 | PENTA-PIROXICAM CAPSULES | PENTAPHARM LTD. | Capsule | PIROXICAM 10 MG | Cancelled (Unreturned Annual) |
| 02230066 | PIROXICAM CAPSULES 10MG | PREMPHARM INC | Capsule | PIROXICAM 10 MG | Cancelled Post Market |
| 02230067 | PIROXICAM CAPSULES 20MG | PREMPHARM INC | Capsule | PIROXICAM 20 MG | Cancelled Post Market |
| 00836249 | PMS-PIROXICAM | PHARMASCIENCE INC | Capsule | PIROXICAM 10 MG | Cancelled Post Market |
| 00836230 | PMS-PIROXICAM | PHARMASCIENCE INC | Capsule | PIROXICAM 20 MG | Cancelled Post Market |
| 02154463 | PMS-PIROXICAM SUPPOSITORIES -20MG | PHARMASCIENCE INC | Suppository | PIROXICAM 20 MG | Cancelled Post Market |
| 02154420 | PMS-PIROXICAM SUPPOSITORIES-10MG | PHARMASCIENCE INC | Suppository | PIROXICAM 10 MG | Cancelled Post Market |
| 00658839 | PRO-PIROXICAM CAP 10MG | PRO DOC LIMITEE | Tablet | PIROXICAM 10 MG | Cancelled Post Market |
| 00658820 | PRO-PIROXICAM CAP 20MG | PRO DOC LIMITEE | Capsule | PIROXICAM 20 MG | Cancelled Post Market |
| 02144212 | RHO-PIROXICAM - 10MG CAP | RHODIAPHARM INC | Capsule | PIROXICAM 10 MG | Cancelled Post Market |
| 02144220 | RHO-PIROXICAM - CAP 20MG | RHODIAPHARM INC | Capsule | PIROXICAM 20 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 17087 | 2015-07-15 | Supplement to a New Drug Submission (SNDS) | PRODUCT NAME CHANGE |
| 15716 | 2014-06-12 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
International API supply for PIROXICAM
5 valid EDQM Certificates of Suitability from 5 holders. 5 active FDA Drug Master Files.
Request a quote for TEVA-PIROXICAM